Announcements Trials
Browse Landscape

Status

Recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 11Genitourinary 6Tumor-Agnostic 3Plasma cell 3Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Gastrointestinal 1Endocrine 1Dermatologic 1CNS 1

Conditions

Pain 1Melanoma 1Lymphedema 1Depression 1Cicatrix 1Anxiety Disorders 1

Interventions

Ipilimumab 123pembrolizumab 101Nivolumab 100aldesleukin 89Cyclophosphamide 85fludarabine phosphate 64Interleukin-2 58Dacarbazine 573-ingenyl angelate 42Vemurafenib 39Temozolomide 39Imiquimod 39trametinib 37sargramostim 37Peripheral Blood Stem Cell Transplantation 36incomplete Freund's adjuvant 35dabrafenib 32fludarabine 31Radiotherapy 31Aminolevulinic Acid 30Bevacizumab 29Carboplatin 28Whole-Body Irradiation 25Photochemotherapy 25Paclitaxel 25Filgrastim 25Biopsy 25Interferon-alpha 24Cisplatin 23Sorafenib 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Absorptiometry, Photon × Dermatologic × Clear all
NCT02352623 2016-05-26

Quality of Life and Surgical Late Effects of Melanoma Treatment

Herlev Hospital

Completed
435 enrolled
Dermatologic

Anxiety Disorders, Cicatrix, Depression, Lymphedema, Melanoma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡